Randomized Trial: Treatments of Advanced Triple-Negative Breast Cancer Compaired
26 Oct, 2018 | 02:03h | UTCAtezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer – New England Journal of Medicine (free for a limited period)
Commentaries: Not So Fast With Immune Therapy For Breast Cancer – Forbes (free) AND Immunotherapy drugs show some promise against breast cancer – STAT (free)
“…the benefit for most women was small, raising questions about whether the treatment is worth its high cost and side effects.” (from STAT)